Followers | 65 |
Posts | 3805 |
Boards Moderated | 0 |
Alias Born | 03/26/2016 |
Friday, January 04, 2019 4:15:21 PM
don`t listen to me, don`t have a clue!
Recent AGEN News
- Agenus Reports First Quarter 2024 Results • Business Wire • 05/07/2024 11:40:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:39:11 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 11:38:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:31:13 AM
- Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement • Business Wire • 05/01/2024 11:30:00 AM
- Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting • Business Wire • 04/24/2024 02:00:00 PM
- Agenus to Provide First Quarter 2024 Financial Report and Corporate Update • Business Wire • 04/23/2024 11:30:00 AM
- Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer • Business Wire • 04/12/2024 11:30:00 AM
- Agenus Announces Reverse Stock Split of Common Stock • Business Wire • 04/05/2024 08:30:00 PM
- Agenus Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 03/14/2024 11:30:00 AM
- Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024 • Business Wire • 03/06/2024 12:30:00 PM
- Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/05/2024 09:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/29/2024 09:50:48 PM
- Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report • Business Wire • 02/29/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/26/2024 09:24:59 PM
- Agenus to Participate in Leerink Partners Global Biopharma Conference • Business Wire • 02/26/2024 12:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/15/2024 01:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 01:00:11 PM
- Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design • PR Newswire (US) • 02/15/2024 12:02:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:33:12 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 12:00:12 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:11:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 01:00:10 PM
- Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference • Business Wire • 01/31/2024 12:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM